Healios K K (4593)

Currency in JPY
637.0
+5.0(+0.79%)
Closed·
4593 Scorecard
Full Analysis
Analysts anticipate sales growth in the current year
Earnings results expected in 3 days
4593 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
620.0638.0
52 wk Range
161.0747.0
Key Statistics
Bid/Ask
636.00 / 637.00
Prev. Close
632
Open
634
Day's Range
620-638
52 wk Range
161-747
Volume
3.49M
Average Volume (3m)
9.25M
1-Year Change
293.21%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
4593 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
630.0
Downside
-1.10%
Members' Sentiments
Bearish
Bullish
ProTips
High return over the last year

Healios K K News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Neutral
Moving Averages
Buy

Healios K K Company Profile

Healios K.K. engages in the research and development, manufacture, and sale of cell therapy and regenerative medicine products in Japan, Europe, and the United States. The company develops HLCM051, which is preparing for phase 3 clinical trial, as well as preparing for approval for the treatment of acute respiratory distress syndrome; HLCM051, which is in phase 2/3 and phase 3 clinical trial to treat ischemic stroke; and HLCM051, which is in phase 2 clinical trial to treat trauma. It also develops HLCR011, which is in phase 1/2 clinical trial for the treatment of retinal pigmen epithelium and age-related macular degeneration; and HLCN061, which is in discovery and preclinical trial for treating solid tumors. The company was formerly known as Retina Institute Japan, K.K. and changed its name to Healios K.K. in September 2013. Healios K.K. was incorporated in 2011 and is headquartered in Tokyo, Japan.

Compare 4593 to Peers and Sector

Metrics to compare
4593
Peers
Sector
Relationship
P/E Ratio
−14.8x−6.6x−0.5x
PEG Ratio
−0.400.040.00
Price/Book
33.1x4.5x2.6x
Price / LTM Sales
109.9x38.2x3.3x
Upside (Analyst Target)
−1.1%92.5%43.4%
Fair Value Upside
Unlock20.8%7.1%Unlock

Analyst Ratings

2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 630.0
(-1.10% Downside)

Earnings

Latest Release
May 13, 2025
EPS / Forecast
-26.72 / --
Revenue / Forecast
38.00M / --
EPS Revisions
Last 90 days

4593 Income Statement

People Also Watch

16,740.0
7013
0.00%
7,217.0
7453
-1.81%
3,285.0
3905
+7.35%
11,095.0
5803
-3.61%

FAQ

What Stock Exchange Does Healios K K Trade On?

Healios K K is listed and trades on the Tokyo Stock Exchange stock exchange.

What Is the Stock Symbol for Healios K K?

The stock symbol for Healios K K is "4593."

What Is the Healios K K Market Cap?

As of today, Healios K K market cap is 64.63B.

What Is Healios K K's Earnings Per Share (TTM)?

The Healios K K EPS (TTM) is -47.75.

When Is the Next Healios K K Earnings Date?

Healios K K will release its next earnings report on 12 Aug 2025.

From a Technical Analysis Perspective, Is 4593 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Healios K K Stock Split?

Healios K K has split 0 times.

How Many Employees Does Healios K K Have?

Healios K K has 65 employees.

What is the current trading status of Healios K K (4593)?

As of 10 Aug 2025, Healios K K (4593) is trading at a price of 637.00, with a previous close of 632.00. The stock has fluctuated within a day range of 620.00 to 638.00, while its 52-week range spans from 161.00 to 747.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.